✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

AbCellera Biologics Inc.

Common Name
Abcellera Biologics
Country
Canada
Sector
Healthcare
Industry
Biotechnology
Employees
596
Ticker
ABCL
Exchange
Nasdaq
Description
AbCellera Biologics Inc. is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines. Its platform combines biology, computation, engineering, and data sci...

Abcellera Biologics's Revenues Data

Explore Abcellera Biologics's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
75,128,000a
28,833,000a
38,025,000a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Abcellera Biologics’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Abcellera Biologics's 10-K 2025